Literature DB >> 18952821

Thermodynamic examination of trinucleotide bulged RNA in the context of HIV-1 TAR RNA.

Ian Carter-O'Connell1, David Booth, Bryan Eason, Neena Grover.   

Abstract

RNA structures contain many bulges and loops that are expected to be sites for inter- and intra-molecular interactions. Nucleotides in the bulge are expected to influence the structure and recognition of RNA. The same stability is assigned to all trinucleotide bulged RNA in the current secondary structure prediction models. In this study thermal denaturation experiments were performed on four trinucleotide bulged RNA, in the context of HIV-1 TAR RNA, to determine whether the bulge sequence affects RNA stability and its divalent ion interactions. Cytosine-rich bulged RNA were more stable than uracil-rich bulged RNA in 1 M KCl. Interactions of divalent ions were more favorable with uracil-rich bulged RNA by approximately 2 kcal/mol over cytosine-rich bulged RNA. The UCU-TAR RNA (wild type) is stabilized by 1.7 kcal/mol in 9.5 mM Ca(2+) as compared with 1 M KCl, whereas no additional gain in stability is measured for CCC-TAR RNA. These results have implications for base substitution experiments traditionally employed to identify metal ion binding sites. To our knowledge, this is the first systematic study to quantify the effect of small sequence changes on RNA stability upon interactions with divalent ions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18952821      PMCID: PMC2590961          DOI: 10.1261/rna.1004108

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  32 in total

1.  Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.

Authors:  M G Cordingley; R L LaFemina; P L Callahan; J H Condra; V V Sardana; D J Graham; T M Nguyen; K LeGrow; L Gotlib; A J Schlabach
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Fragments of the HIV-1 Tat protein specifically bind TAR RNA.

Authors:  K M Weeks; C Ampe; S C Schultz; T A Steitz; D M Crothers
Journal:  Science       Date:  1990-09-14       Impact factor: 47.728

3.  Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein.

Authors:  M A Muesing; D H Smith; D J Capon
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

4.  Role of a bulged A residue in a specific RNA-protein interaction.

Authors:  H N Wu; O C Uhlenbeck
Journal:  Biochemistry       Date:  1987-12-15       Impact factor: 3.162

5.  A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.

Authors:  S Roy; U Delling; C H Chen; C A Rosen; N Sonenberg
Journal:  Genes Dev       Date:  1990-08       Impact factor: 11.361

6.  Specific binding of arginine to TAR RNA.

Authors:  J Tao; A D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.

Authors:  C Dingwall; I Ernberg; M J Gait; S M Green; S Heaphy; J Karn; A D Lowe; M Singh; M A Skinner; R Valerio
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  Conformation of the TAR RNA-arginine complex by NMR spectroscopy.

Authors:  J D Puglisi; R Tan; B J Calnan; A D Frankel; J R Williamson
Journal:  Science       Date:  1992-07-03       Impact factor: 47.728

9.  Arginine-mediated RNA recognition: the arginine fork.

Authors:  B J Calnan; B Tidor; S Biancalana; D Hudson; A D Frankel
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

10.  Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure.

Authors:  David H Mathews; Matthew D Disney; Jessica L Childs; Susan J Schroeder; Michael Zuker; Douglas H Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

View more
  8 in total

1.  Thermodynamic examination of the pyrophosphate sensor helix in the thiamine pyrophosphate riboswitch.

Authors:  Stephanie Furniss; Neena Grover
Journal:  RNA       Date:  2011-03-02       Impact factor: 4.942

2.  Quantifying the temperature dependence of glycine-betaine RNA duplex destabilization.

Authors:  Jeffrey J Schwinefus; Ryan J Menssen; James M Kohler; Elliot C Schmidt; Alexandra L Thomas
Journal:  Biochemistry       Date:  2013-11-22       Impact factor: 3.162

3.  Thermodynamic examination of 1- to 5-nt purine bulge loops in RNA and DNA constructs.

Authors:  Shane Strom; Evgenia Shiskova; Yaeeun Hahm; Neena Grover
Journal:  RNA       Date:  2015-05-28       Impact factor: 4.942

4.  Improved model to predict the free energy contribution of trinucleotide bulges to RNA duplex stability.

Authors:  Meghan H Murray; Jessicah A Hard; Brent M Znosko
Journal:  Biochemistry       Date:  2014-05-22       Impact factor: 3.162

5.  Analysis of RNA nearest neighbor parameters reveals interdependencies and quantifies the uncertainty in RNA secondary structure prediction.

Authors:  Jeffrey Zuber; B Joseph Cabral; Iain McFadyen; David M Mauger; David H Mathews
Journal:  RNA       Date:  2018-08-13       Impact factor: 4.942

6.  Non-enzymatic template-directed recombination of RNAs.

Authors:  Sergey Y Nechaev; Alexei V Lutay; Valentin V Vlassov; Marina A Zenkova
Journal:  Int J Mol Sci       Date:  2009-04-21       Impact factor: 6.208

7.  Increasing the length of poly-pyrimidine bulges broadens RNA conformational ensembles with minimal impact on stacking energetics.

Authors:  Dawn K Merriman; Jiayi Yuan; Honglue Shi; Ananya Majumdar; Daniel Herschlag; Hashim M Al-Hashimi
Journal:  RNA       Date:  2018-07-16       Impact factor: 4.942

8.  Thermodynamic examination of pH and magnesium effect on U6 RNA internal loop.

Authors:  Allison A O'Connell; Jared A Hanson; Darryl C McCaskill; Ethan T Moore; Daniel C Lewis; Neena Grover
Journal:  RNA       Date:  2019-09-23       Impact factor: 4.942

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.